Consistently, the level of OXA in CSF exhibited an evidently positive correlation with Tau and pTau in patients with moderate to severe AD (Liguori et al., 2014), and even in control subjects (Shimizu et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.